Genmab — Juli 2020
-
NBI: -2,42%
-
Er der mere nyt om Trump´s plan for at sænke medicinpriser i US. Udkastet skulle komme i dag.
-
Dutch healthcare institute expects Teprotumumab to be filed in 2020 in EMA https://www.horizonscangeneesmiddelen.nl/geneesmiddelen/teprotumumab-chronische-immuunziekten-chronische-immuunziekten-overig/versie4
-
Vi kunne godt bruge noget positivt...storm efter stilhed;-)
-
Jeps..nohope..vi må tage til takke med de små glæder..:-)
-
inden det begynder at storme;-)
-
German biotech firm CureVac files for U.S. IPO https://uk.reuters.com/article/uk-curevac-ipo-idUKKCN24P2AD
-

-
Hvad er jeres kommentar til dette: Mener ceo ikke mente det var et problem.? https://www.marketscreener.com/GENMAB-A-S-63733191/news/Genmab-A-S-GSK-s-blood-cancer-drug-wins-European-panel-thumbs-up-30984060/
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind